142 related articles for article (PubMed ID: 28890093)
1. Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody.
Hofmann D; Zak SE; Nyakatura EK; Mittler E; Bakken RR; Chandran K; Dye JM; Lai JR
Immunol Lett; 2017 Oct; 190():289-295. PubMed ID: 28890093
[TBL] [Abstract][Full Text] [Related]
2. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
[TBL] [Abstract][Full Text] [Related]
3. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
Konduru K; Bradfute SB; Jacques J; Manangeeswaran M; Nakamura S; Morshed S; Wood SC; Bavari S; Kaplan GG
Vaccine; 2011 Apr; 29(16):2968-77. PubMed ID: 21329775
[TBL] [Abstract][Full Text] [Related]
4. Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge.
Chen G; Koellhoffer JF; Zak SE; Frei JC; Liu N; Long H; Ye W; Nagar K; Pan G; Chandran K; Dye JM; Sidhu SS; Lai JR
ACS Chem Biol; 2014 Oct; 9(10):2263-73. PubMed ID: 25140871
[TBL] [Abstract][Full Text] [Related]
5. Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
Bounds CE; Kwilas SA; Kuehne AI; Brannan JM; Bakken RR; Dye JM; Hooper JW; Dupuy LC; Ellefsen B; Hannaman D; Wu H; Jiao JA; Sullivan EJ; Schmaljohn CS
PLoS One; 2015; 10(9):e0137786. PubMed ID: 26422247
[TBL] [Abstract][Full Text] [Related]
6. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
7. The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.
Lennemann NJ; Walkner M; Berkebile AR; Patel N; Maury W
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S204-9. PubMed ID: 26038399
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a Novel Neutralizing Monoclonal Antibody Against Ebola Virus GP.
Reynard O; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S372-8. PubMed ID: 26232760
[TBL] [Abstract][Full Text] [Related]
9. Differential requirements for FcγR engagement by protective antibodies against Ebola virus.
Bournazos S; DiLillo DJ; Goff AJ; Glass PJ; Ravetch JV
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20054-20062. PubMed ID: 31484758
[TBL] [Abstract][Full Text] [Related]
10. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk.
King LB; West BR; Moyer CL; Gilchuk P; Flyak A; Ilinykh PA; Bombardi R; Hui S; Huang K; Bukreyev A; Crowe JE; Saphire EO
Nat Commun; 2019 Apr; 10(1):1788. PubMed ID: 30996276
[TBL] [Abstract][Full Text] [Related]
11. Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).
Sobarzo A; Groseth A; Dolnik O; Becker S; Lutwama JJ; Perelman E; Yavelsky V; Muhammad M; Kuehne AI; Marks RS; Dye JM; Lobel L
J Infect Dis; 2013 Jul; 208(2):299-309. PubMed ID: 23585686
[TBL] [Abstract][Full Text] [Related]
12. Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail.
Froude JW; Herbert AS; Pelat T; Miethe S; Zak SE; Brannan JM; Bakken RR; Steiner AR; Yin G; Hallam TJ; Sato AK; Hust M; Thullier P; Dye JM
Viruses; 2018 May; 10(6):. PubMed ID: 29861435
[TBL] [Abstract][Full Text] [Related]
13. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region.
Flyak AI; Kuzmina N; Murin CD; Bryan C; Davidson E; Gilchuk P; Gulka CP; Ilinykh PA; Shen X; Huang K; Ramanathan P; Turner H; Fusco ML; Lampley R; Kose N; King H; Sapparapu G; Doranz BJ; Ksiazek TG; Wright DW; Saphire EO; Ward AB; Bukreyev A; Crowe JE
Nat Microbiol; 2018 Jun; 3(6):670-677. PubMed ID: 29736037
[TBL] [Abstract][Full Text] [Related]
14. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
[TBL] [Abstract][Full Text] [Related]
15. Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI.
Radinsky O; Edri A; Brusilovsky M; Fedida-Metula S; Sobarzo A; Gershoni-Yahalom O; Lutwama J; Dye J; Lobel L; Porgador A
Sci Rep; 2017 Jul; 7(1):6054. PubMed ID: 28729706
[TBL] [Abstract][Full Text] [Related]
16. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors.
Sobarzo A; Stonier SW; Radinsky O; Gelkop S; Kuehne AI; Edri A; Herbert AS; Fedida-Metula S; Lutwama JJ; Yavelsky V; Davis C; Porgador A; Dye JM; Lobel L
EBioMedicine; 2019 Aug; 46():215-226. PubMed ID: 31326432
[TBL] [Abstract][Full Text] [Related]
17. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
[TBL] [Abstract][Full Text] [Related]
18. A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.
Gunn BM; Lu R; Slein MD; Ilinykh PA; Huang K; Atyeo C; Schendel SL; Kim J; Cain C; Roy V; Suscovich TJ; Takada A; Halfmann PJ; Kawaoka Y; Pauthner MG; Momoh M; Goba A; Kanneh L; Andersen KG; Schieffelin JS; Grant D; Garry RF; Saphire EO; Bukreyev A; Alter G
Immunity; 2021 Apr; 54(4):815-828.e5. PubMed ID: 33852832
[TBL] [Abstract][Full Text] [Related]
19. Immune memory to Sudan virus: comparison between two separate disease outbreaks.
Sobarzo A; Eskira Y; Herbert AS; Kuehne AI; Stonier SW; Ochayon DE; Fedida-Metula S; Balinandi S; Kislev Y; Tali N; Lewis EC; Lutwama JJ; Dye JM; Yavelsky V; Lobel L
Viruses; 2015 Jan; 7(1):37-51. PubMed ID: 25569078
[TBL] [Abstract][Full Text] [Related]
20. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
